Anaesthesia, surgery, and life-threatening allergic reactions: management and outcomes in the 6th National Audit Project (NAP6)

British Journal of Anaesthesia

Volumn 121, Issue 1, 2018, Pages 172-188

  Harper, N J N ^a,b,c   Cook, T M ^c,d,e   Garcez, T ^a   Lucas, D N ^f   Thomas, M ^g   Kemp, H ^h   Kong, K L ⁱ   Marinho, S ^a   Karanam, S ⁱ   Ferguson, K ^j   Hitchman, J ^c   Torevell, H ^t   Warner, A ^k   Egner, W ^l,m   Nasser, S ⁿ   McGuire, N ^o   Bellamy, M ^p,q   Floss, K ^r   Farmer, L ^c   Farooque, S ^s  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ROYAL COLLEGE OF ANAESTHETISTS   (United Kingdom)

^d ROYAL UNITED HOSPITAL   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f NORTHWICK PARK HOSPITAL   (United Kingdom)

^g GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁱ SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

^j ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^k Age UK   (United Kingdom)

^l SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^m UNIVERSITY OF SHEFFIELD   (United Kingdom)

ⁿ CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^o MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

^p LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^q UNIVERSITY OF LEEDS   (United Kingdom)

^r OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^s IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^t Imperial College Healthcare NHS Trust ^*

more..

Author keywords

allergy; anaesthesia; anaphylaxis; outcome; perioperative

Indexed keywords

ANTIHISTAMINIC AGENT; CATECHOLAMINE; CHLORPHENIRAMINE; CORTICOSTEROID; EPINEPHRINE; GLUCAGON; INFUSION FLUID; ROCURONIUM; SUGAMMADEX; VASOACTIVE AGENT; VASOPRESSIN; VASOCONSTRICTOR AGENT;

ALLERGIC REACTION; ANESTHESIA; ANESTHESIST; ARTICLE; CARDIOVASCULAR DISEASE; FATALITY; HEART ARREST; HOSPITALIZATION; HUMAN; HYPOTENSION; INTENSIVE CARE; OBSTETRIC PROCEDURE; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESPIRATION CONTROL; RESUSCITATION; SURGICAL APPROACH; SURGICAL TECHNIQUE; TREATMENT OUTCOME; ADULT; ANAPHYLAXIS; CHILD; CLINICAL AUDIT; DRUG HYPERSENSITIVITY; EPIDEMIOLOGY; FLUID THERAPY; HEART MASSAGE; MORTALITY; PERIOPERATIVE PERIOD; SURGERY; UNITED KINGDOM;

ADULT; ANAPHYLAXIS; ANESTHESIA; CARDIOPULMONARY RESUSCITATION; CHILD; DRUG HYPERSENSITIVITY; EPINEPHRINE; FLUID THERAPY; HEART MASSAGE; HUMANS; MEDICAL AUDIT; PERIOPERATIVE PERIOD; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME; UNITED KINGDOM; VASOCONSTRICTOR AGENTS;

EID: 85047055322     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1016/j.bja.2018.04.015     Document Type: Article

References (56)

1. Harper, N.J.N., Cook, T.M., Garcez, T., et al. Anaesthesia, surgery and life threatening allergic reactions. Epidemiology and clinical features of perioperative anaphylaxis: the 6th National Audit Project. Br J Anaesth 121 (2018), 159–171.
2. Reich, D., Hossain, S., Krol, M., et al. Predictors of hypotension after induction of general anesthesia. Anesth Analg 101 (2005), 622–628.
3. Harper, N.J.N., Dixon, T., Dugué, et al. Guidelines suspected anaphylactic reactions associated with anaesthesia. Anaesthesia 64 (2009), 199–211.
4. Mirakian, R., Ewan, P.W., Durham, S.R., et al. BSACI guidelines for the management of drug allergy. Clin Exp Allergy 39 (2009), 43–61.
5. Kroigaard, M., Garvey, L.H., Gillberg, L., et al. Scandinavian Clinical Practice Guidelines on the diagnosis, management and follow-up of anaphylaxis during anaesthesia. Acta Anaesthesiol Scand 51 (2007), 655–670.
6. National Institute for Health and Clinical Excellence CG 183. Drug allergy: diagnosis and management of drug allergy in adults, children and young people. Available from https://www.nice.org.uk/guidance/cg183 [Accessed 7 March 2018].
7. Simons, F.E.R., Ardusso, L.R.F., Bilo, M.B., et al. World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol 127 (2011), 587–593.
8. National Institute for Health and Clinical Excellence, NICE clinical guideline 134: anaphylaxis: assessment and referral after emergency treatment. 2011 Available from https://www.nice.org.uk/guidance/cg134. (Accessed 30 May 2018)
9. Emergency treatment of anaphylactic reactions: guidelines for healthcare providers, 2016, Resuscitation council, UK Available from https://www.resus.org.uk/anaphylaxis/emergency-treatment-of-anaphylactic-reactions/. (Accessed 6 February 2018)
10. Scolaro, R., Crilly, H., Maycock, E., et al. Australian and New Zealand anaesthetic allergy group (ANZAAG) perioperative anaphylaxis investigation guidelines. Anaesth Intensive Care 45 (2017), 543–555.
11. Mertes, P.M., Malinovsky, J.M., Jouffroy, L., et al. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol 21 (2011), 442–453.
12. Schummer, C., Wirsing, M., Schummer, W., The pivotal role of vasopressin in refractory anaphylactic shock. Anesth Analg 107 (2008), 620–624.
13. Bensghir, M., Atmani, M., Elwali, A., Azendour, H., Kamili, N.D., Successful treatment by vasopressin of a refractory rocuronium-induced anaphylactic shock: case report. Egypt J Anaesth 29 (2013), 175–178.
14. Meng, L., Williams, E., Case report: treatment of rocuronium-induced anaphylactic shock with vasopressin. Can J Anesth 55 (2008), 437–440.
15. Hussain, A.M., Yousuf, B., Khan, M.A., Khan, F.H., Khan, F.A., Vasopressin for the management of catecholamine-resistant anaphylactic shock. Singapore Med 49 (2008), 225–228.
16. Zaloga, G., Delacey, W., Holmboe, E., Chernow, B., Glucagon reversal of hypotension in a case of anaphylactoid shock. Ann Intern Med 105 (1986), 66–67.
17. Javeed, N., Javeed, H., Javeed, S., Moussa, G., Wong, P., Rezai, F., Refractory anaphylactoid shock potentiated by beta-blockers. Cathet Cardiovasc Diagn 39 (1996), 384–385.
18. Liu, M.C., Proud, D., Lichtenstein, L.M., et al. Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects. J Allergy Clin Immunol 108 (2001), 29–38.
19. Sheikh, A., Ten Broek, V., Brown, S.G.A., Simons, F.E.R., H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy Eur J Allergy Clin Immunol 62 (2007), 830–837.
20. Cook, T.M., Harper, N.J.N., Farmer, L., et al. Anaesthesia, surgery and life-threatening allergic reactions: protocol and methods of the 6th National Audit Project (NAP6) of the royal College of anaesthetists. Br J Anaesth 121 (2018), 159–171.
21. Kemp, H.I., Cook, T.M., Thomas, M., Harper, N.J.N., UK anaesthetists' perspectives and experiences of severe perioperative anaphylaxis: NAP6 baseline survey. Br J Anaesth 119 (2017), 132–139.
22. Egner, W., Cook, T.M., Harper, N.J., et al. Specialist peri-operative allergy clinic services in the UK 2016: results from the royal College of anaesthetists Sixth national Audit project. Clin Exp Allergy 47 (2017), 1318–1330.
23. Kemp, H., Marinho, S., Cook, T., et al. An observational national study of anaesthetic workload and seniority across the working week and weekend in the UK in 2016: the 6th National Audit Project (NAP6) Activity Survey. Br J Anaesth 121 (2018), 134–145.
24. Marinho, S., Kemp, H., Cook, T.M., et al. A cross-sectional study of anaesthetic drug exposure in United Kingdom practice. The NAP6 Allergen Survey. Br J Anaesth 121 (2018), 146–158.
25. Egner, W., Cook, T., Garcez, T., et al. Specialist perioperative allergy clinic services in the UK 2018: results from the royal College of anaesthetists Sixth National Audit Project (NAP6) investigation of perioperative anaphylaxis. Clin Exp Allergy, 2018 In press.
26. Soar, J., Nolan, J.P., Böttiger, B.W., et al. European resuscitation Council guidelines for resuscitation 2015: section 3. Adult advanced life support. Resuscitation 95 (2015), 100–147.
27. Deakin, C.D., Low, J.L., Accuracy of the advanced trauma life support guidelines for predicting systolic blood pressure using carotid, femoral, and radial pulses: observational study. BMJ 321 (2000), 673–674.
28. Lehman, L.W.H., Saeed, M., Talmor, D., Mark, R., Malhotra, A., Methods of blood pressure measurement in the ICU. Crit Care Med 41 (2013), 34–40.
29. Pumphrey, R.S.H., Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 30 (2000), 1144–1150.
30. McLean-Tooke, A., Bethune, C., Fay, A., Spickett, G., Adrenaline in the treatment of anaphylaxis: what is the evidence?. BMJ 327 (2003), 1332–1335.
31. Kawano, T., Scheuermeyer, F.X., Stenstrom, R., Rowe, B.H., Grafstein, E., Grunau, B., Epinephrine use in older patients with anaphylaxis: clinical outcomes and cardiovascular complications. Resuscitation 112 (2017), 53–58.
32. Garvey, L.H., Belhage, B., Krøigaard, M., Husum, B., Malling, H.-J., Mosbech, H., Treatment with epinephrine (adrenaline) in suspected anaphylaxis during anesthesia in Denmark. Anesthesiology 115 (2011), 111–116.
33. Johnston, E., King, C., Sloane, P., et al. Pediatric anaphylaxis in the operating room for anesthesia residents: a simulation study. Pediatr Anesth 27 (2017), 205–210.
34. Gibbison, B., Sheikh, A., McShane, P., Haddow, C., Soar, J., Anaphylaxis admissions to UK critical care units between 2005 and 2009. Anaesthesia 67 (2012), 833–838.
35. McDonnell, N.J., Pavy, T.J.G., Green, L.K., Platt, P.R., Sugammadex in the management of rocuronium-induced anaphylaxis. Br J Anaesth 106 (2011), 199–201.
36. Kawano, T., Tamura, T., Hamaguchi, M., Yatabe, T., Yamashita, K., Yokoyama, M., Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report. J Clin Anesth 24 (2012), 62–64.
37. Barthel, F., Stojeba, N., Lyons, G., Biermann, C., Diemunsch, P., Sugammadex in rocuronium anaphylaxis: dose matters. Br J Anaesth 109 (2012), 646–647.
38. Clarke, R.C., Sadleir, P.H.M., Platt, P.R., The role of sugammadex in the development and modification of an allergic response to rocuronium: evidence from a cutaneous model. Anaesthesia 67 (2012), 266–273.
39. Platt, P.R., Clarke, R.C., Johnson, G.H., Sadleir, P.H.M., Efficacy of sugammadex in rocuronium-induced or antibiotic-induced anaphylaxis. A case-control study. Anaesthesia 70 (2015), 1264–1267.
40. Savic, L., Garside, M., Savic, S., Hopkins, P., Anaphylaxis follow-up: making it simple - making it better. Bull R Coll Anaesth 87 (2014), 33–34.
41. Sadleir, P.H.M., Clarke, R.C., Bozic, B., Platt, P.R., Consequences of proceeding with surgery after resuscitation from intra-operative anaphylaxis. Anaesthesia 73 (2018), 32–39.
42. Lennox, C., Marr, L., Scottish confidential Audit of severe maternal morbidity: reducing avoidable harm. 10th annual report, 2014, Healthcare Improvement Scotland Available from http://www.healthcareimprovementscotland.org/our_work/reproductive,_maternal_child/programme_resources/scasmm.aspx. (Accessed 20 February 2018)
43. Mulla, Z.D., Ebrahim, M.S., Gonzalez, J.L., Anaphylaxis in the obstetric patient: analysis of a statewide hospital discharge database. Ann Allergy Asthma Immunol 104 (2010), 55–59.
44. McCall, S.J., Bunch, K.J., Brocklehurst, P., et al. The incidence, characteristics, management and outcomes of anaphylaxis in pregnancy: a population-based descriptive study. Int J Obs Anesth, 26, 2016, S9.
45. Hepner, D.L., Castells, M., Mouton-Faivre, C., Dewachter, P., Anaphylaxis in the clinical setting of obstetric anesthesia: a literature review. Anesth Analg 117 (2013), 1357–1367.
46. Baraka, A., Sfeir, S., Anaphylactic cardiac arrest in a parturient: response of the newborn. JAMA 243 (1980), 1745–1746.
47. Kinsella, S.M., Carvalho, B., Dyer, R.A., et al. International consensus statement on the management of hypotension with vasopressors during caesarean section under spinal anaesthesia. Anaesthesia 73 (2018), 71–92.
48. Hood, D., Dewan, D., James, F., Maternal and fetal effects of epinephrine in gravid ewes. Anesthesiology 64 (1986), 610–613.
49. Murat, I., Anaphylactic reactions during paediatric anaesthesia; results of the survey of the French Society of Paediatric Anaesthetists (ADARPEF) 1991–1992. Pediatr Anesth 3 (1993), 339–343.
50. Mertes, P.M., Alla, F., Tréchot, P., et al. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol 128 (2011), 366–373.
51. Habre, W., Disma, N., Virag, K., et al. Incidence of severe critical events in paediatric anaesthesia (APRICOT): a prospective multicentre observational study in 261 hospitals in Europe. Lancet Respir Med 5 (2017), 412–425.
52. Simon, L., Boucebci, K.J., Orliaguet, G., Aubineau, J.V., Devys, J.M., Dubousset, A.M., A survey of practice of tracheal intubation without muscle relaxant in paediatric patients. Paediatr Anaesth 12 (2002), 36–42.
53. Newsom, S.W., Shaw, M., A survey of starch particle counts in the hospital environment in relation to the use of powdered latex gloves. Occup Med (Lond) 47 (1997), 155–158.
54. Kelly, K., Pearson, M., Kurup, V., et al. A cluster of anaphylactic reactions in children with spina bifida during general anesthesia: epidemiologic features, risk factors, and latex hypersensitivity. J Allergy Clin Immunol 94 (1994), 53–61.
55. Cook, T.M., Payne, S., Anns, J., One year on from NAP3: dissemination and clinical changes after the third national Audit project of the royal College of anaesthetists. Br J Anaesth 107 (2011), 978–982.
56. Cook, T.M., Woodall, N., Frerk, C., A national survey of the impact of NAP4 on airway management practice in United Kingdom hospitals: closing the safety gap in anaesthesia, intensive care and the emergency department. Br J Anaesth 117 (2016), 182–190.